In Other News

• New Pooling Strategy Increases Efficiency and Reduces Cost of COVID-19 PCR Tests

• AI-Powered COVID-19 Cough Analyzer App Assesses Respiratory Health and Associated Risks

• New CE-Marked ELISA Test Detects COVID-19 Antibodies in Recently Infected People with Mild Symptoms

• First-of-Its-Kind Mobile Testing Platform Launched to Manage and Track On-Site COVID-19 Testing

• Abbott's USD 5, 15-Minute BinaxNOW COVID-19 Ag Card Becomes First Diagnostic Test with Read-Result Test Card to Receive FDA EUA

• Coronavirus Screening Platform Uses Machine Learning Algorithms to Detect SARS-CoV-2 Structural Fingerprint in Real Time

• Fluidigm’s Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay Secures FDA Emergency Use Authorization

• Novel Coronavirus Breathalyzer Test Detects COVID-19 Non-Invasively in Seconds

• Novel SERS Assay Could Identify Superspreaders Carrying Coronavirus Mutations

• First-Ever Saliva-Based COVID and Influenza Combo Test to Screen for Coronavirus and Flu Infections

• New COVID-19 Pooling Test Method Identifies Asymptomatic Carriers

• Zymo Research’s Quick SARS-CoV-2 rRT-PCR Kit Receives CE-IVD Mark

• Beckman Coulter Launches New SARS-CoV-2 Immunoglobulin M (IgM) Antibody Test

• Use of COVID-19 Tests without FDA Approval Could Bring New, Innovative Tests to Market More Quickly

• OpGen Launches Own-Developed CE-IVD Marked Molecular Diagnostic SARS-CoV-2 Kit with PULB in Europe

• COVID-19 Fuelling Growth of In-Vitro Diagnostics Market and Creating Novel Opportunities for Players

• Tests to Detect Common Immune Signature in Blood of COVID-19 Patients Could Predict Severity of Disease

• LumiraDx SARS-CoV-2 Antigen Test Granted FDA Emergency Use Authorization

• Quidel’s Point-of-Care Sofia SARS Antigen FIA Test for COVID-19 to Offer New Kit Configuration

• Ultra-High-Volume COVID-19 Test to Enable Genomic Diagnostic Testing and Population Screening For 40,000 Samples per Day

• QIAGEN Launches QIAseq SARS-CoV-2 Primer Panel for Next-Generation Sequencing Of Novel Coronavirus Genome to Accelerate COVID-19 Research

• Accelerate Diagnostics’ COVID-19 Antibody Testing System Granted FDA Emergency Use Authorization

• Diazyme Secures Second FDA Emergency Use Authorization for COVID-19 Antibody Test